Catalyst Wire Dossier Catalyst Wire Dossier

Ovarian cancer vaccine (CAN-003)

· Prima BioMed Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ovarian cancer vaccine (CAN-003), covering 2017-12-08 to 2017-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study [Phase 2]

See pricing